Z-1650-2021 Class II Terminated

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-1650-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Apr 7, 2021 and is designated Class II. Reason for recall: The device may contain a manufacturing defect of a missing resistance spot weld (RSW). The recall status is terminated (terminated Aug 23, 2024). Affected quantity: 2 units.

Recall details

Product Type
Devices
Report Date
May 26, 2021
Initiation Date
Apr 7, 2021
Termination Date
Aug 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 units

Product description

Cobalt HF Quad MRI SureScan Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D) - Product Usage: are multiprogrammable cardiac devices that monitor and regulate a patient s heart rate by providing single- or dual chamber rate responsive bradycardia pacing, cardioversion, and defibrillation therapies.

Reason for recall

The device may contain a manufacturing defect of a missing resistance spot weld (RSW).

Distribution pattern

US Nationwide distribution in the state of North Carolina.

Code information

Product Number: DTPB2D4, UDI: 00763000178215 Serial Numbers: RTO601595S and RTO601624S

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1650-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1650-2021. Report a data issue: hello@regdatalab.com.